Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Alx Oncology Holdings (ALXO) Other Non-Current Assets (2019 - 2023)

Alx Oncology Holdings' Other Non-Current Assets history spans 5 years, with the latest figure at $10.9 million for Q2 2023.

  • For Q2 2023, Other Non-Current Assets changed N/A year-over-year to $10.9 million; the TTM value through Jun 2023 reached $10.9 million, changed N/A, while the annual FY2022 figure was $14.9 million, 21.72% up from the prior year.
  • Other Non-Current Assets for Q2 2023 was $10.9 million at Alx Oncology Holdings, up from $144000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $15.7 million in Q1 2022 and bottomed at $7000.0 in Q4 2019.
  • The 5-year median for Other Non-Current Assets is $8.8 million (2021), against an average of $6.9 million.
  • The largest annual shift saw Other Non-Current Assets surged 122570.0% in 2021 before it plummeted 99.08% in 2023.
  • A 5-year view of Other Non-Current Assets shows it stood at $7000.0 in 2019, then soared by 42.86% to $10000.0 in 2020, then soared by 122570.0% to $12.3 million in 2021, then rose by 21.72% to $14.9 million in 2022, then fell by 27.03% to $10.9 million in 2023.
  • Per Business Quant, the three most recent readings for ALXO's Other Non-Current Assets are $10.9 million (Q2 2023), $144000.0 (Q1 2023), and $14.9 million (Q4 2022).